Model
Edge
Adamas Pharmaceuticals Inc
0001328143
Filing Type
8-K
Filing Date
11/23/2021
Updated
11/24/21, 2:18 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2